Table 2.
Treatments planned and received during the COVID-19 pandemic by World Bank income group
| Low-income countries % (n/N) |
Lower-middle income countries % (n/N) |
Upper-middle income countries % (n/N) |
High-income countries % (n/N) |
|
| Multi-disciplinary team (MDT) management plan during the pandemic | ||||
| Chemotherapy | 86.1 (31/36) | 89.4 (685/766) | 84.0 (544/648) | 91.0 (608/668) |
| Radiotherapy | 16.7 (6/36) | 16.7 (128/766) | 12.7 (82/648) | 16.8 (112/668) |
| Immunotherapy | 0.0 (0/36) | 0.3 (2/766) | 2.9 (19/648) | 5.8 (39/668) |
| Surgery | 30.6 (11/36) | 31.9 (244/766) | 33.0 (214/648) | 28.6 (191/668) |
| Palliative care | 8.3 (3/36) | 0.8 (6/766) | 0.5 (3/648) | 0.6 (4/668) |
| MDT plan that would have been proposed prior to the pandemic | ||||
| Chemotherapy | 86.1 (31/36) | 90.2 (691/766) | 83.8 (543/648) | 91.0 (608/668) |
| Radiotherapy | 16.7 (6/36) | 17.1 (131/766) | 12.8 (83/648) | 16.8 (112/668) |
| Immunotherapy | 0.0 (0/36) | 0.5 (4/766) | 2.9 (19/648) | 5.8 (39/668) |
| Surgery | 30.6 (11/36) | 31.1 (238/766) | 32.9 (213/648) | 28.6 (191/668) |
| Palliative care | 8.3 (3/36) | 0.5 (4/766) | 0.5 (3/648) | 0.6 (4/668) |
| Treatment provided within 30 days for patients planned to have that treatment at MDT | ||||
| Chemotherapy | 80.6 (25/31) | 84.7 (559/660) | 86.4 (389/450) | 87.8 (496/565) |
| Radiotherapy | 0.0 (0/6) | 22.0 (28/127) | 44.4 (20/45) | 42.2 (43/102) |
| Immunotherapy | – | 100.0 (2/2) | 75.0 (12/16) | 55.9 (19/34) |
| Surgery | 18.2 (2/11) | 27.6 (62/225) | 36.4 (60/165) | 36.4 (63/173) |
| Treatment provided within 90 days for patients planned to have that treatment at MDT | ||||
| Chemotherapy | 80.6 (25/31) | 88.9 (601/676) | 88.7 (481/542) | 91.3 (553/606) |
| Radiotherapy | 0.0 (0/6) | 48.0 (60/125) | 39.0 (32/82) | 46.8 (52/111) |
| Immunotherapy | – | 100.0 (2/2) | 89.5 (17/19) | 69.2 (27/39) |
| Surgery | 18.2 (2/11) | 84.0 (110/131) | 38.8 (83/214) | 47.1 (89/189) |
| Treatment provided within 12 months for patients planned to have that treatment at MDT | ||||
| Chemotherapy | 90.0 (27/30) | 96.6 (625/647) | 95.1 (504/530) | 93.7 (562/600) |
| Radiotherapy | 0.0 (0/6) | 62.7 (69/110) | 49.4 (40/81) | 54.7 (58/106) |
| Immunotherapy | – | 100.0 (2/2) | 89.5 (17/19) | 83.3 (30/36) |
| Surgery | 45.5 (5/11) | 75.7 (159/210) | 66.0 (132/200) | 64.0 (119/186) |
| Treatment provided within 12 months for all patients | ||||
| Chemotherapy | 84.9 (28/33) | 92.5 (649/702) | 88.9 (552/621) | 88.4 (577/653) |
| Radiotherapy | 0.0 (0/30) | 16.6 (93/560) | 20.8 (119/571) | 12.7 (76/599) |
| Immunotherapy | 0.0 (0/30) | 1.5 (8/547) | 9.8 (54/551) | 10.7 (64/597) |
| Surgery | 22.6 (7/31) | 37.2 (226/607) | 34.6 (202/584) | 33.7 (207/615) |